相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A patent review of BRD4 inhibitors (2013-2019)
Tian Lu et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
Andjelija Zivanovic Bujak et al.
PLOS MEDICINE (2020)
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
Everett J. Moding et al.
NATURE CANCER (2020)
Circulating tumor DNA and liquid biopsy in oncology
David W. Cescon et al.
NATURE CANCER (2020)
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3
Sara Ballabio et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Aparna R. Parikh et al.
NATURE MEDICINE (2019)
Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
Minyong Kang et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2019)
Parallel Evaluation of Circulating Tumor DNA and Circulating Tumor Cells in Metastatic Colorectal Cancer
Giovanni Germano et al.
CLINICAL COLORECTAL CANCER (2018)
Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients
S. Valpione et al.
EUROPEAN JOURNAL OF CANCER (2018)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Genomic analysis of head and neck cancer cases from two high incidence regions
Sandra Perdomo et al.
PLOS ONE (2018)
Enhanced detection of circulating tumor DNA by fragment size analysis
Florent Mouliere et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
Christopher Abbosh et al.
NATURE (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients
Nadine Van Roy et al.
CLINICAL CANCER RESEARCH (2017)
Tumor Cell-Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy
Glen J. Weiss et al.
CLINICAL CANCER RESEARCH (2017)
Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer Updated Guidelines From the European Group on Tumor Markers
Gyorgy Soletormos et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Jacob J. Chabon et al.
NATURE COMMUNICATIONS (2016)
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
Faye R. Harris et al.
SCIENTIFIC REPORTS (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Genetic predisposition to ductal carcinoma in situ of the breast
Christos Petridis et al.
BREAST CANCER RESEARCH (2016)
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study
L. Beltrame et al.
ANNALS OF ONCOLOGY (2015)
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
Giulia Siravegna et al.
NATURE MEDICINE (2015)
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer
Isaac Garcia-Murillas et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Elena Pereira et al.
PLOS ONE (2015)
Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities
Angela Esposito et al.
CANCER TREATMENT REVIEWS (2014)
Liquid Biopsies: Genotyping Circulating Tumor DNA
Luis A. Diaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Identification of genomic alterations in oesophageal squamous cell cancer
Yongmei Song et al.
NATURE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
Muhammed Murtaza et al.
NATURE (2013)
Emerging landscape of oncogenic signatures across human cancers
Giovanni Ciriello et al.
NATURE GENETICS (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence
Kristin R. Delfino et al.
PLOS ONE (2013)
Aberrantly expressed AURKC enhances the transformation and tumourigenicity of epithelial cells
Jen-Hui Tsou et al.
JOURNAL OF PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Aurora kinase inhibitors as anti-cancer therapy
Warren Lok et al.
ANTI-CANCER DRUGS (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Anticancer drugs up-regulate HspBP1 and thereby antagonize the prosurvival function of hsp70 in tumor cells
Susumu Tanimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)